Summary:
The study will evaluate the safety of the vaccine and its ability to generate an immune response against Influenza.
Qualified Participants Must:
Be atleast 18 years of age and healthy.
Qualified Participants May Receive:
Up to $100 per visit. Up to $650 for qualified participants